Zhejiang
China
20
2025-11-27
The entities that hold a legal rights for patent applications filed by inventor Ding Lieming:
Lieming Ding from Zhejiang, CN has applied for patents for these inventions. The list has both pending applications and granted patents:
HPK1 INHIBITOR AND MEDICAL USE THEREOF
#2 | 2025-07-10MACROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#3 | 2025-05-15PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING ACTIVE INGREDIENT COMPOUND THEREOF
#4 | 2024-07-25Polymorph Of Imidazolidinone Compound, Preparation Method Therefor And Use Thereof
#5 | 2023-12-07BICYCLIC COMPOUNDS, COMPOSITIONS AND USE THEREOF
#6 | 2023-10-26SHP2 INHIBITOR AND COMPOSITION AND APPLICATION THEREOF
#7 | 2023-07-13QUINAZOLINE COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF
#8 | 2023-06-22SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF
#9 | 2023-04-27QUINOLYL PHOSPHINE OXIDE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF
#10 | 2023-01-26Compound functioning as bromodomain protein inhibitor, and composition
#11 | 2022-07-21EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF
#12 | 2022-03-31Immunomodulators, compositions and methods thereof
#13 | 2022-03-03EGFR Inhibitors, Compositions and Methods Thereof
#14 | 2022-01-06FGFR4 INHIBITOR AND USE THEREOF
#15 | 2021-12-23TYROSINE KINASE INHIBITORS, COMPOSITIONS AND METHODS THERE OF
#16 | 2021-11-04SALT FORM AND CRYSTAL FORM OF NOVEL AZATRICYCLIC COMPOUND AND USE THEREOF
#17 | 2021-08-26ERK inhibitor and use thereof
#18 | 2021-08-26Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof
#19 | 2020-12-10Compound functioning as bromodomain protein inhibitor, and composition
#20 | 2016-04-21Polymorphic forms of icotinib and uses thereof
1504581 ⎘